LPL Financial
CRDF icon

LPL Financial’s Cardiff Oncology CRDF Stock Holding History

LPL Financial’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,784
Closed -$40K – 4471
2022
Q3 		$40K Sell
25,784
-600
-2% -$1.44K ﹤0.01% 4258
2022
Q2 		$58K Buy
26,384
+3,998
+18% +$6.7K ﹤0.01% 4216
2022
Q1 		$56K Sell
22,386
-297
-1% -$1.05K ﹤0.01% 4044
2021
Q4 		$136K Buy
22,683
+5,083
+29% +$30.3K ﹤0.01% 4070
2021
Q3 		$117K Hold
17,600
– – ﹤0.01% 4103
2021
Q2 		$117K Buy
17,600
+1,500
+9% +$12.7K ﹤0.01% 4036
2021
Q1 		$149K Buy
16,100
+136
+0.9% +$1.65K ﹤0.01% 3848
2020
Q4 		$287K Buy
15,964
+1,814
+13% +$31.9K ﹤0.01% 3233
2020
Q3 		$201K Buy
+14,150
New +$93.4K ﹤0.01% 3200

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

LPL Financial's CRDF Position: Q4 2022 in Review

LPL Financial sold out of Cardiff Oncology (CRDF) in Q4 2022, closing a stake of 25,784 shares — an estimated $40K sold.

LPL Financial first reported a position in CRDF in Q3 2020 and held it in 9 quarters. The position peaked at $287K in Q4 2020. 60 funds tracked by Wall St. Rank hold CRDF as of Q4 2022.

  • LPL Financial reported no remaining Cardiff Oncology position as of Q4 2022 after selling out during the quarter.
  • LPL Financial sold 25,784 Cardiff Oncology shares in Q4 2022, an estimated $40K.
  • LPL Financial first reported a position in Cardiff Oncology in Q3 2020 and held it in 9 quarters.
  • LPL Financial's Cardiff Oncology position peaked at $287K in Q4 2020.
  • 60 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2022.

Based on LPL Financial's 13F filing for Q4 2022, filed 7 Feb 2023.